SARS-CoV-2 Spike Protein Neutralizing Antibody (Bebtelovimab) | abx376552

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Spike Protein RBD Neutralizing Antibody (Bebtelovimab) is a research grade Human Monoclonal Antibody for the detection of SARS-CoV-2/COVID-19 Spike Protein.
The SARS-CoV-2 Spike Protein (S protein) is a viral protein that allows the entry of SARS-CoV-2 into human cells. The protein forms trimers on the viral capsid and binds to human Angiotensin Converting Enzyme 2 (ACE2) located on the cell surface. The protein has a cleavage site between the S1 and S2 subunits that is targeted by the human enzyme Furin, and it may also cause the development of a syncytium (cell fusion). Antibodies to S protein can prevent viral entry as well as target the virus for further immune action.

Target: SARS-CoV-2 Spike Protein
Clonality: Monoclonal
Reactivity: Virus
Host: Human
Recommended dilutions: Optimal dilutions/concentrations should be determined by the end user.
Conjugation: Unconjugated
Isotype: IgG1 Lambda
Form: Liquid
Purity: > 95%
Purification: Purified by Protein A or G.
Storage: Aliquot and store at -20 °C. Avoid repeated freeze/thaw cycles.